Top Chief Complaints and Diagnoses for Outpatient Dermatology Patients of Color.

IF 1.5 4区医学 Q3 DERMATOLOGY

Journal of Drugs in Dermatology Pub Date : 2025-04-01 DOI:10.36849/JDD.8532

Arielle Carolina Mora Hurtado, Sarah Gonzalez, Nicole C Syder, Melissa Gonzalez, Sanmeet Atwal, Kayla Blair, Ivan Rodriguez, Audrey Hao, Autumn L Saizan, Simone N Montgomery, Jack Rodman, Nada Elbuluk

{"title":"Top Chief Complaints and Diagnoses for Outpatient Dermatology Patients of Color.","authors":"Arielle Carolina Mora Hurtado, Sarah Gonzalez, Nicole C Syder, Melissa Gonzalez, Sanmeet Atwal, Kayla Blair, Ivan Rodriguez, Audrey Hao, Autumn L Saizan, Simone N Montgomery, Jack Rodman, Nada Elbuluk","doi":"10.36849/JDD.8532","DOIUrl":null,"url":null,"abstract":"Background: By 2044, people with skin of color (SOC) in the United States are projected to become the majority of the population, yet research and practice gaps remain regarding the dermatologic conditions most common and concerning to populations with SOC.1,2 Objective: To investigate the most common outpatient dermatologic chief complaints and diagnoses in patients with SOC.Methods: A retrospective chart review was conducted investigating the top chief complaints and diagnoses in children and adult patients with SOC seen at the University of Southern California outpatient dermatology clinics over 10 years, from 2009 to 2019.Results: A total of 4572 individuals were identified (2326 [58.9%] female; mean age [SD]: 46.0 [19.9] years). The 5 most common skin concerns were skin examination (21.5%), bumps/growths (20.8%), rash (19.8%), acne (10.0%), and skin discoloration (8.5%). The 5 most common diagnoses were benign nevi/neoplasm (38.8%), followed by dermatitis (20.8%), acne (13.3%), eczema and/or xerosis (9.0%), and dyspigmentation (7.7%). Differences were observed across racial/ethnic, age, and gender groups.Conclusion: Findings from this study contribute valuable insights regarding the potential motivations for seeking dermatologic care across various demographical groups, underscoring the importance of patient-centered, evidence-based, and culturally competent care in the diagnosis and treatment of dermatological disease across diverse populations. J Drugs Dermatol. 2025;24(4):403-409. doi:10.36849/JDD.8532R1.","PeriodicalId":15566,"journal":{"name":"Journal of Drugs in Dermatology","volume":"24 4","pages":"403-409"},"PeriodicalIF":1.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drugs in Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36849/JDD.8532","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: By 2044, people with skin of color (SOC) in the United States are projected to become the majority of the population, yet research and practice gaps remain regarding the dermatologic conditions most common and concerning to populations with SOC.1,2 Objective: To investigate the most common outpatient dermatologic chief complaints and diagnoses in patients with SOC.

Methods: A retrospective chart review was conducted investigating the top chief complaints and diagnoses in children and adult patients with SOC seen at the University of Southern California outpatient dermatology clinics over 10 years, from 2009 to 2019.

Results: A total of 4572 individuals were identified (2326 [58.9%] female; mean age [SD]: 46.0 [19.9] years). The 5 most common skin concerns were skin examination (21.5%), bumps/growths (20.8%), rash (19.8%), acne (10.0%), and skin discoloration (8.5%). The 5 most common diagnoses were benign nevi/neoplasm (38.8%), followed by dermatitis (20.8%), acne (13.3%), eczema and/or xerosis (9.0%), and dyspigmentation (7.7%). Differences were observed across racial/ethnic, age, and gender groups.

Conclusion: Findings from this study contribute valuable insights regarding the potential motivations for seeking dermatologic care across various demographical groups, underscoring the importance of patient-centered, evidence-based, and culturally competent care in the diagnosis and treatment of dermatological disease across diverse populations. J Drugs Dermatol. 2025;24(4):403-409. doi:10.36849/JDD.8532R1.

查看原文本刊更多论文

门诊有色人种皮肤病患者主诉及诊断。

背景：到2044年，美国有色人种（SOC）预计将成为人口的大多数，但关于SOC人群最常见和最关注的皮肤病的研究和实践仍存在差距。目的：调查SOC患者最常见的门诊皮肤病主诉和诊断。方法：回顾性分析2009年至2019年10年间南加州大学皮肤科门诊儿童和成人SOC患者的主诉和诊断情况。结果：共鉴定出4572只，其中雌性2326只，占58.9%；平均年龄[SD]: 46.0[19.9]岁)。最常见的5种皮肤问题是皮肤检查（21.5%）、肿块/生长（20.8%）、皮疹（19.8%）、痤疮（10.0%）和皮肤变色（8.5%）。最常见的5种诊断是良性痣/肿瘤（38.8%），其次是皮炎（20.8%）、痤疮（13.3%）、湿疹和/或干燥症（9.0%）和色素沉着（7.7%）。在种族/民族、年龄和性别群体中观察到差异。结论：本研究的发现为不同人群寻求皮肤病治疗的潜在动机提供了有价值的见解，强调了以患者为中心、以证据为基础和具有文化能力的护理在不同人群皮肤病诊断和治疗中的重要性。皮肤医学杂志，2025;24(4):403-409。doi: 10.36849 / JDD.8532R1。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Drugs in Dermatology DERMATOLOGY-

CiteScore

2.20

自引率

13.30%

发文量

289

审稿时长

3-6 weeks

期刊介绍： The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology. We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality. Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.